Addictions Therapeutics Market
Addictions Therapeutics Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Addictions Therapeutics Market Size and Growth
The Addictions Therapeutics market is experiencing significant growth driven by increasing substance abuse and mental health challenges. The market size is projected to reach approximately $4.2 billion by 2027, fueled by innovative treatment options and rising awareness. Enhanced regulations and healthcare initiatives are further supporting advancements in addiction therapies.
Companies Covered
(Covid 19 Impact Covered)
◍ Alkermes Plc
◍ Amneal Pharmaceuticals Inc.
◍ Indivior Plc
◍ Johnson & Johnson Services Inc.
◍ Mylan NV
◍ Novartis AG
◍ Novo Nordisk AS
◍ Opiant Pharmaceuticals Inc.
◍ Pfizer Inc.
◍ Teva Pharmaceutical Industries Ltd.
The addictions therapeutics market features key players like Alkermes, Amneal, and Indivior, focused on innovative treatments and expanding access. Companies like Johnson & Johnson and Pfizer enhance market growth through research and development.
Sales revenue examples:
- Alkermes: ~$850 million
- Indivior: ~$700 million
- Pfizer: ~$40 billion (overall revenue)
Request Sample Report
Market Segmentation
By Application
Public
Private
Government
Request Sample Report
By Product
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market Growth
Request Sample Report
$ 4.43 Billion
